CVA Family Office’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$504	Hold	16	–	–	﹤0.01%	1235
2025 Q1	$524	Buy	+16	New	+$524	﹤0.01%	1244
2024 Q4	–	Sell	-14	Closed	-$437	–	1340
2024 Q3	$437	Buy	+14	New	+$437	﹤0.01%	1240